Methods of treating steroid-induced obesity using GLP-1 agonists
First Claim
Patent Images
1. A method of treating steroid-induced obesity in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a GLP-1 agonist for reducing body weight in said subject administered a steroid, wherein the GLP-1 agonist is Arg34Lys26(Nε
- -(γ
-Glu(Nε
-hexadecanoyl)))-GLP-1(7-37).
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
-
Citations
14 Claims
-
1. A method of treating steroid-induced obesity in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a GLP-1 agonist for reducing body weight in said subject administered a steroid, wherein the GLP-1 agonist is Arg34Lys26(Nε
- -(γ
-Glu(Nε
-hexadecanoyl)))-GLP-1(7-37). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
- -(γ
Specification